Tuesday - March 03, 2026

NSCLC Clinical Trial Analysis 2026: 135+ Companies, 150+ Pipeline Therapies, 7+ Recent FDA Milestones Reshaping the Future of Lung Cancer Treatment by DelveInsight

Non-Small Cell Lung Cancer Clinical Trial Major NSCLC companies include BridgeBio Pharma, Daiichi Sankyo, EMD Serono/Merck, AbbVie/Pfizer, Eli Lilly and Company, BioNTech SE, Shenzhen TargetRx, Taiho Pharmaceutical, Chong Kun Dang, Bristol Myers Squibb, Innovent Biologics, Bayer, GeneScience Pharmaceuticals, InventisBio, Apollomics, … Continue reading

Multiple Sclerosis Competitive Landscape 2026: 75+ Companies, 80+ Pipeline Therapies, 15+ Key FDA & Clinical Milestones Driving the Future of Multiple Sclerosis Treatment, analyses DelveInsight

Multiple Sclerosis Competitive Landscape Multiple Sclerosis Companies include Sanofi, Immunic, InnoCare Pharma, Tiziana Life Sciences, Biogen, J-Pharma, Bristol-Myers Squibb, Polpharma Biologics, Repertoire Immune Medicines, Nervgen, Nucleome Therapeutics, Medsenic, TeraImmun, Autobahn Therapeutics, GlaxoSmithKline, ImCyse, Novartis, Biocad, Apimeds, Genentech, Merck, AB Science, … Continue reading

Menkes Disease Market Forecast 2034: FDA Approvals, Competitive Landscape, USD 7.9 Million Market Size in 2023, 177 Diagnosed Cases, & Clinical Pipeline | DelveInsight

Menkes Disease Market Menkes Disease companies working in the market are Cyprium Therapeutics and Sentynl Therapeutics, and others. In 2023, the Menkes disease market remained limited in size but demonstrated steady progression. The United States dominated the 7MM, contributing close … Continue reading

SNS Technologies Expands Community Engagement Through Managed IT Services for Local Arts Nonprofit

SNS Technologies has expanded its community engagement efforts through a managed IT services partnership with a Coastal Carolina arts nonprofit SNS Technologies’ Charleston office expands community engagement through a managed IT services partnership with a Coastal Carolina arts nonprofit, strengthening … Continue reading